Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: STP004
MIFTS: 45

Staphylococcal Toxic Shock Syndrome

Categories: Infectious diseases, Rare diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Staphylococcal Toxic Shock Syndrome

About this section

MalaCards integrated aliases for Staphylococcal Toxic Shock Syndrome:

Name: Staphylococcal Toxic Shock Syndrome 52 71
Bacterial Toxic-Shock Syndrome 52 58
Staphylococcal Toxic-Shock Syndrome 58
Staphylococcal Tss 58
Bacterial Tss 58

Characteristics:

Orphanet epidemiological data:

58
bacterial toxic-shock syndrome
Inheritance: Not applicable; Age of onset: All ages; Age of death: any age;
staphylococcal toxic-shock syndrome
Inheritance: Not applicable; Prevalence: 1-9/1000000 (United States);

Classifications:

MalaCards categories:
Global: Rare diseases Infectious diseases
See all MalaCards categories (disease lists)
ICD10: 33
Orphanet: 58  
Rare infectious diseases


External Ids:

ICD10 via Orphanet 33 A48.3
UMLS via Orphanet 72 C3714602
UMLS 71 C3714602
Sources

Summaries for Staphylococcal Toxic Shock Syndrome

About this section
NIH Rare Diseases : 52 The following summary is from Orphanet , a European reference portal for information on rare diseases and orphan drugs. Orpha Number: 36234 Definition Bacterial toxic shock syndrome (TSS) is a potentially fatal, acute disease characterized by a sudden onset of high fever along with nausea, myalgia, vomiting and multisystem organ involvement, potentially leading to shock and death. TSS is mediated by superantigenic toxins , usually caused by an infection with Staphylococcus aureus in staphylococcal TSS (see this term) or Streptococcus pyogenes in streptococcal TSS (see this term). Epidemiology The worldwide prevalence is estimated at 1/30, 000. Clinical description The disease affects mainly young adult women with no previous medical conditions. However, non-menstrual TSS, which can also be observed in men and children, represents up to 50% of Staphylococcal TSS cases. Onset is sudden and includes high fever (>38.9?C), nausea, diarrhea, vomiting, myalgia, abdominal pain and sore throat. Staphylococcal TSS almost always exhibits an erythematous rash and skin peeling as one of its manifestations, whereas it is very rarely seen in streptococcal TSS, which can show signs of soft tissue infection. Serious manifestations include confusion, shock, renal and myocardial dysfunction, acute respiratory distress syndrome (ARDS; see this term) and coma. Etiology Staphylococcal TSS is due to an infection with Staphylococcus aureus and streptococcal TSS is due to an infection with Streptococcus pyogenes , or rarely, group C or G Streptococcus. Superantigens produced by both bacteria are responsible for the massive and sudden immune reaction seen in TSS. Both forms have been associated with recent traumas (surgery or childbirth) and viral infections, while staphylococcal TSS has also been associated with high absorbency tampon use. Visit the Orphanet disease page for more resources.

MalaCards based summary : Staphylococcal Toxic Shock Syndrome, also known as bacterial toxic-shock syndrome, is related to toxic shock syndrome and exanthem. An important gene associated with Staphylococcal Toxic Shock Syndrome is TNF (Tumor Necrosis Factor), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Clavulanate and Amoxicillin have been mentioned in the context of this disorder. Affiliated tissues include skin, t cells and monocytes, and related phenotypes are arthritis and vomiting

Sources

Related Diseases for Staphylococcal Toxic Shock Syndrome

About this section

Diseases related to Staphylococcal Toxic Shock Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 378)
# Related Disease Score Top Affiliating Genes
1 toxic shock syndrome 31.6 TNF IL1B IFNG HMGB1 CIITA
2 exanthem 30.3 TNF IL1B IFNG
3 pharyngitis 30.2 TNF IL1B
4 chickenpox 30.1 TNF IFNG
5 diarrhea 29.7 TNF IL1B IFNG
6 neutropenia 29.6 TNF IL1B IFNG
7 osteomyelitis 29.6 TNF IL1B IFNG
8 aspergillosis 29.6 TNF IL1B IFNG
9 allergic hypersensitivity disease 29.5 TNF IGHE IFNG
10 immune deficiency disease 29.4 TNF IFNG CIITA
11 conjunctivitis 29.3 TNF IGHE IFNG
12 autoimmune disease 29.1 TNF IL1B IFNG CIITA
13 dermatitis, atopic 29.0 TNF IL1B IGHE IFNG
14 staphylococcal scarlet fever 12.0
15 physiological polycythemia 10.2 TNF IL1B
16 systemic onset juvenile idiopathic arthritis 10.2 TNF IL1B
17 vulvar vestibulitis syndrome 10.2 TNF IL1B
18 palladium allergic contact dermatitis 10.2 TNF IL1B
19 kashin-beck disease 10.2 TNF IL1B
20 congenital cytomegalovirus 10.2 TNF IL1B
21 anaerobic pneumonia 10.2 TNF IL1B
22 jejunoileitis 10.2 TNF IL1B
23 metal allergy 10.2 TNF IL1B
24 actinic prurigo 10.2 TNF IL1B
25 macrophage activation syndrome 10.2 TNF HMGB1
26 stachybotrys chartarum 10.2 TNF IL1B
27 post-cardiac arrest syndrome 10.2 TNF HMGB1
28 carbuncle 10.2 TNF IL1B
29 chemical colitis 10.2 TNF IL1B
30 aortitis 10.2 TNF IL1B
31 palindromic rheumatism 10.2 TNF IL1B
32 anthracosis 10.2 TNF IL1B
33 pneumonic tularemia 10.2 TNF IL1B
34 tularemia 10.2 TNF IL1B
35 chlamydia pneumonia 10.2 TNF IL1B
36 lumbosacral lipoma 10.2 TNF IL1B
37 peptic esophagitis 10.2 TNF IL1B
38 bursitis 10.2 TNF IL1B
39 irritant dermatitis 10.2 TNF IL1B
40 background diabetic retinopathy 10.2 TNF IL1B
41 autoimmune vasculitis 10.2 TNF IL1B
42 periapical periodontitis 10.2 TNF IL1B
43 laryngitis 10.2 TNF IL1B
44 dental pulp disease 10.2 TNF IL1B
45 vaginal discharge 10.2 TNF IL1B
46 orchitis 10.2 TNF IL1B
47 trichomoniasis 10.2 TNF IL1B
48 glossitis 10.2 TNF IL1B
49 funisitis 10.2 TNF IL1B
50 urethritis 10.2 TNF IL1B

Graphical network of the top 20 diseases related to Staphylococcal Toxic Shock Syndrome:



Diseases related to Staphylococcal Toxic Shock Syndrome
Sources

Symptoms & Phenotypes for Staphylococcal Toxic Shock Syndrome

About this section

Human phenotypes related to Staphylococcal Toxic Shock Syndrome:

58 (show top 50) (show all 60)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 arthritis 58 Occasional (29-5%)
2 vomiting 58 Occasional (29-5%)
3 renal insufficiency 58 Occasional (29-5%)
4 fever 58 Frequent (79-30%)
5 elevated serum creatine kinase 58 Occasional (29-5%)
6 sinusitis 58 Occasional (29-5%)
7 edema 58 Very rare (<4-1%)
8 skin rash 58 Occasional (29-5%)
9 abnormal blistering of the skin 58 Occasional (29-5%)
10 hepatitis 58 Occasional (29-5%)
11 recurrent urinary tract infections 58 Very rare (<4-1%)
12 abdominal pain 58 Frequent (79-30%)
13 osteomyelitis 58 Occasional (29-5%)
14 myalgia 58 Frequent (79-30%)
15 myositis 58 Occasional (29-5%)
16 thrombocytopenia 58 Occasional (29-5%)
17 increased serum lactate 58 Frequent (79-30%)
18 cellulitis 58 Occasional (29-5%)
19 hypocalcemia 58 Occasional (29-5%)
20 myocarditis 58 Occasional (29-5%)
21 meningitis 58 Occasional (29-5%)
22 sepsis 58 Occasional (29-5%)
23 abnormality of the upper limb 58 Occasional (29-5%)
24 encephalitis 58 Occasional (29-5%)
25 hypoalbuminemia 58 Occasional (29-5%)
26 abnormality of the lower limb 58 Occasional (29-5%)
27 metabolic acidosis 58 Frequent (79-30%)
28 tachycardia 58 Frequent (79-30%)
29 tachypnea 58 Occasional (29-5%)
30 respiratory distress 58 Frequent (79-30%)
31 pneumonia 58 Occasional (29-5%)
32 hypotension 58 Very frequent (99-80%)
33 diarrhea 58 Occasional (29-5%)
34 respiratory tract infection 58 Occasional (29-5%)
35 fasciitis 58 Frequent (79-30%)
36 peritonitis 58 Occasional (29-5%)
37 confusion 58 Frequent (79-30%)
38 abscess 58 Occasional (29-5%)
39 septic arthritis 58 Occasional (29-5%)
40 recurrent skin infections 58 Frequent (79-30%)
41 disseminated intravascular coagulation 58 Occasional (29-5%)
42 pain 58 Frequent (79-30%)
43 glomerulonephritis 58 Occasional (29-5%)
44 localized skin lesion 58 Occasional (29-5%)
45 scaling skin 58 Occasional (29-5%)
46 elevated serum creatinine 58 Occasional (29-5%)
47 nausea 58 Occasional (29-5%)
48 capillary leak 58 Occasional (29-5%)
49 chills 58 Occasional (29-5%)
50 pharyngitis 58 Occasional (29-5%)
Sources

Drugs & Therapeutics for Staphylococcal Toxic Shock Syndrome

About this section

Drugs for Staphylococcal Toxic Shock Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 18)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Clavulanate Approved, Vet_approved Phase 4 58001-44-8 5280980
2
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
3
Rifampicin Approved Phase 4 13292-46-1 5381226 5458213
4
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
5
Imidacloprid Vet_approved Phase 4 105827-78-9 86418
6 Antibodies Phase 4
7 Rho(D) Immune Globulin Phase 4
8 Immunoglobulins, Intravenous Phase 4
9 Clindamycin phosphate Phase 4
10 Anti-Bacterial Agents Phase 4
11 Pharmaceutical Solutions Phase 4
12 Clindamycin palmitate Phase 4
13 gamma-Globulins Phase 4
14 Immunologic Factors Phase 4
15 Amoxicillin-Potassium Clavulanate Combination Phase 4
16 Immunoglobulins Phase 4
17 Antibiotics, Antitubercular Phase 4
18
Proline Nutraceutical Phase 4 147-85-3 145742

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children: a Multicentre European Randomized Controlled Trial Not yet recruiting NCT02899702 Phase 4 PRIVIGEN (CSL Behring);Albumin

Search NIH Clinical Center for Staphylococcal Toxic Shock Syndrome

Sources

Genetic Tests for Staphylococcal Toxic Shock Syndrome

About this section
Sources

Anatomical Context for Staphylococcal Toxic Shock Syndrome

About this section

MalaCards organs/tissues related to Staphylococcal Toxic Shock Syndrome:

40
Skin, T Cells, Monocytes, Breast, B Cells, Bone, Testes
Sources

Publications for Staphylococcal Toxic Shock Syndrome

About this section

Articles related to Staphylococcal Toxic Shock Syndrome:

(show top 50) (show all 190)
# Title Authors PMID Year
1
Staphylococcal toxic shock syndrome in a child with interleukin-17 inhibitor treatment for psoriasis. 61
32533569 2020
2
An Elusive Case of Mycosis Fungoides: Case Report and Review of the Literature. 61
31388911 2019
3
Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection. 61
31597722 2019
4
[Staphylococcal toxic shock syndrome should be considered in the event of diffuse erythema with fever and shock]. 61
30691878 2019
5
Molecular Typing and Variations in Amount of tst Gene Expression of TSST-1-Producing Clinical Staphylococcus aureus Isolates. 61
31275293 2019
6
[Intravenous immunoglobulin therapy in non-menstrual staphylococcal toxic shock syndrome]. 61
29050863 2018
7
Clinical and Molecular Epidemiology of Staphylococcal Toxic Shock Syndrome in the United Kingdom. 61
29350159 2018
8
Erratum: Intense, flu-like symptoms in women using menstrual devices: always think of staphylococcal Toxic Shock Syndrome. 61
28721224 2017
9
Staphylococcus enterotoxin profile of China isolates and the superantigenicity of some novel enterotoxins. 61
28235987 2017
10
Intense, flu-like symptoms in women using menstrual devices: always think of staphylococcal Toxic Shock Syndrome. 61
28580155 2017
11
[Staphylococcal toxic shock syndrome at a chronic hemodialysis]. 61
28979632 2017
12
HLA-DR polymorphisms influence in vivo responses to staphylococcal toxic shock syndrome toxin-1 in a transgenic mouse model. 61
27863161 2017
13
Fatal endocarditis with methicilin-sensible Staphylococcus aureus and major complications: rhabdomyolysis, pericarditis, and intracerebral hematoma: A case report and review of the literature. 61
27741135 2016
14
Acute encephalopathy with biphasic seizures and late reduced diffusion associated with staphylococcal toxic shock syndrome caused by burns. 61
27117386 2016
15
Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial. 61
27296693 2016
16
Nosocomial Staphylococcal Toxic Shock. Case Report. 61
29967853 2016
17
Lactobacilli require physical contact to reduce staphylococcal TSST-1 secretion and vaginal epithelial inflammatory response. 61
27060097 2016
18
The Management of Staphylococcal Toxic Shock Syndrome. A Case Report. 61
29967843 2016
19
Staphylococcal Toxic Shock Syndrome Caused by an Intravaginal Product. A Case Report. 61
29967837 2016
20
Unusual staphylococcal toxic shock syndrome presenting as a scarlet-like fever. 61
26543563 2015
21
Staphylococcal Purpura Fulminans: Report of a Case. 61
25099358 2015
22
A fatal case of staphylococcal toxic shock syndrome. 61
26265799 2015
23
Evidence of staphylococcal toxic shock syndrome caused by MRSA in a mother-newborn pair. 61
25260039 2015
24
Neutralization of staphylococcal enterotoxin B by an aptamer antagonist. 61
25624325 2015
25
[Severe burns related to steam inhalation therapy]. 61
24768268 2015
26
Staphylococcal toxic shock syndrome caused by tampon use. 61
25692047 2015
27
[Staphylococcal toxic shock syndrome after breast surgery]. 61
24636869 2014
28
Staphylococcal toxic shock syndrome: superantigen-mediated enhancement of endotoxin shock and adaptive immune suppression. 61
24816557 2014
29
The impact of Staphylococcus aureus-associated molecular patterns on staphylococcal superantigen-induced toxic shock syndrome and pneumonia. 61
25024509 2014
30
Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome. 61
24423010 2014
31
Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice. 61
23985881 2013
32
Images in clinical medicine. Staphylococcal toxic shock syndrome. 61
23984732 2013
33
Clinical features and etiology of adult patients with Fever and rash. 61
23197907 2012
34
Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1. 61
22431984 2012
35
Evolutionary blueprint for host- and niche-adaptation in Staphylococcus aureus clonal complex CC30. 61
22919639 2012
36
[Staphylococcal toxic shock syndrome in a 5 year-old child]. 61
21470720 2011
37
Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics. 61
21860665 2011
38
Toxigenic status of Staphylococcus aureus isolated from bovine raw milk and Minas frescal cheese in Brazil. 61
21219740 2010
39
Staphylococcal toxic shock syndrome: mechanisms and management. 61
21308522 2010
40
Toxic shock syndrome toxin-1 (TSST-1) antibody levels in Japanese children. 61
20036064 2010
41
Use of recombinant human activated protein C in nonmenstrual staphylococcal toxic shock syndrome. 61
21253349 2010
42
TLR2 signalling: At the crossroads of commensalism, invasive infections and toxic shock syndrome by Staphylococcus aureus. 61
20363358 2010
43
Staphylococcal toxic shock syndrome, superantigenicity, and hypersensitivity. 61
20367234 2010
44
Staphylococcus aureus exotoxins are present in vivo in tampons. 61
20335433 2010
45
Staphylococcal toxic shock syndrome presenting as acute respiratory distress and cor pulmonale. 61
20196940 2010
46
Staphylococcal toxic shock syndrome erythroderma is associated with superantigenicity and hypersensitivity. 61
19911998 2009
47
Evaluation of surveillance methods for staphylococcal toxic shock syndrome. 61
19402965 2009
48
Biological characterization of the zinc site coordinating histidine residues of staphylococcal enterotoxin C2. 61
19246739 2009
49
Tigecycline attenuates staphylococcal superantigen-induced T-cell proliferation and production of cytokines and chemokines. 61
19874226 2009
50
Analysis of the early response to TSST-1 reveals Vbeta-unrestricted extravasation, compartmentalization of the response, and unresponsiveness but not anergy to TSST-1. 61
18923105 2009
Sources

Variations for Staphylococcal Toxic Shock Syndrome

About this section
Sources

Expression for Staphylococcal Toxic Shock Syndrome

About this section
Search GEO for disease gene expression data for Staphylococcal Toxic Shock Syndrome.
Sources

Pathways for Staphylococcal Toxic Shock Syndrome

About this section

Pathways related to Staphylococcal Toxic Shock Syndrome according to GeneCards Suite gene sharing:

(show all 49)
# Super pathways Score Top Affiliating Genes
1
Innate Immune System 65
Show member pathways
 13.72 TNF IL1B IGHE IFNG HMGB1 CIITA
2
Cytokine Signaling in Immune system 65
Show member pathways
 13.09 TNF IL1B IGHE IFNG CIITA
3
IL-2 Pathway 63
Show member pathways
 12.98 TNF IL1B IFNG HMGB1
4
Allograft rejection 1 36
Show member pathways
 12.65 TNF IL1B IFNG CIITA
5
Measles 36
Show member pathways
 12.61 TNF IL1B IFNG CIITA
6
4-1BB Pathway 63
Show member pathways
 12.47 TNF IL1B IFNG
7
T cell receptor signaling pathway 36
Show member pathways
 12.41 TNF IL1B IFNG
8
Th17 cell differentiation 36
Show member pathways
 12.4 TNF IL1B IFNG
9
Immune response IL-23 signaling pathway 22
Show member pathways
 12.39 TNF IL1B IFNG
10
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways 65
Show member pathways
 12.35 TNF IFNG HMGB1
11
NF-kappaB Signaling 4
12.34 TNF IL1B IFNG CIITA
12
IL-17 Family Signaling Pathways 64
Show member pathways
 12.16 TNF IL1B IFNG
13
Folate Metabolism 1
Show member pathways
 12.15 TNF IL1B IFNG
14
Toll Comparative Pathway 63
Show member pathways
 12.13 TNF IL1B IFNG
15
Immune response IFN alpha/beta signaling pathway 22
Show member pathways
 12.07 TNF IL1B IFNG
16
Bacterial infections in CF airways 22
Show member pathways
 12.02 TNF IL1B IFNG
17
Fluid shear stress and atherosclerosis 36
11.94 TNF IL1B IFNG
18
Osteoclast differentiation 36
11.9 TNF IL1B IFNG
19
Toxoplasmosis 36
Show member pathways
 11.9 TNF IL1B IFNG CIITA
20
Spinal Cord Injury 1
11.85 TNF IL1B IFNG
21
Interleukin-4 and 13 signaling 65
11.82 TNF IL1B IGHE
22
IL27-mediated signaling events 1
Show member pathways
 11.78 TNF IL1B IFNG
23
Amoebiasis 36
11.75 TNF IL1B IFNG
24
Tuberculosis 36
11.71 TNF IL1B IFNG CIITA
25
Rheumatoid arthritis 36
11.7 TNF IL1B IFNG
26
Immune response IFN gamma signaling pathway 22
Show member pathways
 11.69 IL1B IFNG
27
Innate Lymphoid Cells Differentiation 64
11.63 TNF IL1B IFNG
28
Dendritic Cells Developmental Lineage Pathway 64
11.58 TNF IL1B IFNG
29
Photodynamic therapy-induced NF-kB survival signaling 1
Show member pathways
 11.49 TNF IL1B IFNG
30
Photodynamic therapy-induced AP-1 survival signaling. 1
11.41 TNF IFNG
31
Cellular Transformation by HTLV1 63
Show member pathways
 11.41 TNF IFNG
32
Interleukin-10 signaling 65
11.39 TNF IL1B
33
amb2 Integrin signaling 1
11.38 TNF HMGB1
34
Malaria 36
11.37 TNF IL1B IFNG
35
MSP-RON Signaling 63
11.33 TNF IL1B IFNG
36
Monoamine Transport 1
Show member pathways
 11.31 TNF IL1B
37
Aryl Hydrocarbon Receptor Pathway 1
11.31 TNF IL1B IFNG
38
Transcription_Role of VDR in regulation of genes involved in osteoporosis 22
11.26 TNF IL1B IFNG
39
IL-15 Signaling and its Primary Biological Effects in Different Immune Cell Types 64
Show member pathways
 11.23 TNF IFNG
40
IL-10 Pathway 63
11.21 TNF IL1B
41
Antifolate resistance 36
11.15 TNF IL1B
42
Type II interferon signaling (IFNG) 1
11.15 IL1B IFNG CIITA
43
Necroptosis 36
Show member pathways
 11.15 TNF IL1B IFNG HMGB1
44
African trypanosomiasis 36
11.11 TNF IL1B IFNG
45
IL1 and megakaryocytes in obesity 1
11.05 IL1B IFNG
46
Cellular roles of Anthrax toxin 1
10.98 TNF IL1B
47
Development and heterogeneity of the ILC family 1
10.94 TNF IL1B IFNG
48
LDL Oxidation in Atherogenesis 63
10.84 TNF IL1B
49
Cytokines and Inflammatory Response 1
10.59 TNF IL1B IFNG
Sources

GO Terms for Staphylococcal Toxic Shock Syndrome

About this section

Cellular components related to Staphylococcal Toxic Shock Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.02 TNF IL1B IGHE IFNG HMGB1

Biological processes related to Staphylococcal Toxic Shock Syndrome according to GeneCards Suite gene sharing:

(show all 50)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription by RNA polymerase II GO:0045944 10 TNF IL1B HMGB1 CIITA
2 negative regulation of transcription by RNA polymerase II GO:0000122 9.97 TNF IFNG HMGB1 CIITA
3 inflammatory response GO:0006954 9.88 TNF IL1B HMGB1 CIITA
4 cytokine-mediated signaling pathway GO:0019221 9.86 TNF IL1B IGHE
5 positive regulation of protein phosphorylation GO:0001934 9.82 TNF IL1B IFNG
6 cellular response to lipopolysaccharide GO:0071222 9.82 TNF IL1B HMGB1
7 immune response GO:0006955 9.77 TNF IL1B IGHE IFNG CIITA
8 positive regulation of inflammatory response GO:0050729 9.76 TNF IL1B IFNG
9 positive regulation of JNK cascade GO:0046330 9.74 TNF IL1B HMGB1
10 regulation of insulin secretion GO:0050796 9.72 TNF IL1B IFNG
11 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280 9.71 TNF HMGB1
12 positive regulation of protein complex assembly GO:0031334 9.71 TNF IFNG
13 positive regulation of interferon-gamma production GO:0032729 9.7 TNF IL1B
14 extrinsic apoptotic signaling pathway GO:0097191 9.7 TNF IFNG
15 negative regulation of blood vessel endothelial cell migration GO:0043537 9.7 TNF HMGB1
16 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.7 TNF IL1B HMGB1
17 protein kinase B signaling GO:0043491 9.69 TNF IL1B
18 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240 9.69 TNF IL1B
19 positive regulation of interleukin-6 production GO:0032755 9.69 TNF IL1B HMGB1
20 lipopolysaccharide-mediated signaling pathway GO:0031663 9.68 TNF IL1B
21 positive regulation of cytokine secretion GO:0050715 9.68 TNF IFNG
22 microglial cell activation GO:0001774 9.68 TNF IFNG
23 regulation of I-kappaB kinase/NF-kappaB signaling GO:0043122 9.68 TNF IL1B
24 negative regulation of neurogenesis GO:0050768 9.67 TNF IL1B
25 positive regulation of interleukin-12 production GO:0032735 9.67 IFNG HMGB1
26 positive regulation of phagocytosis GO:0050766 9.67 TNF IL1B IFNG
27 inflammatory response to antigenic stimulus GO:0002437 9.66 IL1B HMGB1
28 positive regulation of osteoclast differentiation GO:0045672 9.66 TNF IFNG
29 positive regulation of amyloid-beta formation GO:1902004 9.65 TNF IFNG
30 positive regulation of glial cell proliferation GO:0060252 9.65 TNF IL1B
31 positive regulation of nitric oxide biosynthetic process GO:0045429 9.65 TNF IL1B IFNG
32 negative regulation of lipid catabolic process GO:0050995 9.64 TNF IL1B
33 positive regulation of interleukin-6 biosynthetic process GO:0045410 9.63 TNF IL1B
34 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.63 TNF IL1B
35 positive regulation of chemokine (C-X-C motif) ligand 2 production GO:2000343 9.62 TNF HMGB1
36 positive regulation of neuroinflammatory response GO:0150078 9.62 TNF IL1B
37 negative regulation of amyloid-beta clearance GO:1900222 9.61 TNF IFNG
38 positive regulation of MHC class II biosynthetic process GO:0045348 9.61 IFNG CIITA
39 positive regulation of interleukin-1 beta biosynthetic process GO:0050725 9.6 TNF IFNG
40 regulation of establishment of endothelial barrier GO:1903140 9.59 TNF IL1B
41 positive regulation of interleukin-8 production GO:0032757 9.58 TNF IL1B HMGB1
42 positive regulation of fever generation GO:0031622 9.56 TNF IL1B
43 sequestering of triglyceride GO:0030730 9.54 TNF IL1B
44 astrocyte activation GO:0048143 9.5 TNF IL1B IFNG
45 positive regulation of vitamin D biosynthetic process GO:0060557 9.46 TNF IFNG
46 positive regulation of nitrogen compound metabolic process GO:0051173 9.43 TNF IFNG
47 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.43 TNF IL1B IFNG
48 positive regulation of chemokine biosynthetic process GO:0045080 9.33 TNF IL1B IFNG
49 positive regulation of interleukin-6 secretion GO:2000778 9.26 TNF IL1B IFNG HMGB1
50 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 8.8 TNF IL1B IFNG

Molecular functions related to Staphylococcal Toxic Shock Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 transcription regulatory region sequence-specific DNA binding GO:0000976 9.33 TNF HMGB1 CIITA
2 transcription regulatory region DNA binding GO:0044212 9.13 TNF HMGB1 CIITA
3 cytokine activity GO:0005125 8.92 TNF IL1B IFNG HMGB1
Sources

Sources for Staphylococcal Toxic Shock Syndrome

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....